Citations

Mayo Clinic

Showing 10 of 108523 citations.

Long‐Term Outcome of IPAA in Patients Presenting with Fulminant Ulcerative Colitis: A Matched Cohort Study
Fasen, Geoffrey S., Pandian, T.K. , Pavey, Emily S., Dozois, Eric J. , Boostrom, Sarah Y., Fasen, Geoffrey

World Journal of Surgery | June 11, 2015 | Volume: 39 | Issue: 10 | Pages: 2590-2594

10.1007/s00268-015-3114-5 | PMID 26067636 Get It

AbstractBackgroundStudies reveal that ileal pouch‐anal anastomosis (IPAA) has long‐term success. These reports, however, use well‐selected cohorts and exclude patients presenting with fulminant colitis (FC). Herein, we aimed to characterize long‐term functional outcomes in patients with fulminant ulcerative colitis (UC) undergoing IPAA.MethodsA prospective database identified patients who underwent IPAA between 1998 and 2008. Patients with FC and chronic UC were matched by age, gender, date of surgery, and follow‐up duration. Clinical and laboratory parameters, immunomodulator use at the time of surgery, and functional outcomes were compared.ResultsForty patients with FC and 73 patients with chronic UC were identified. Preoperative albumin, hemoglobin, leukocyte count, and steroid dose were significantly different for those with FC. Average survey follow‐up was 5.2 years for FC and 6.7 years for chronic UC patients. Functional outcomes were not significantly different. The 3‐year fistula‐free rate was 91.4 versus 98.6 % and the 3‐year stricture‐free rate was 79.3 versus 87.2 % for FC versus chronic UC patients, respectively.ConclusionPatients undergoing colectomy for FC secondary to UC have similar long‐term functional outcomes after IPAA despite significantly worse presentation. This study confirms that IPAA is an appropriate and durable treatment for patients with FC.
Pilot Trial of Selecting Molecularly Guided Therapy for Patients with Non–V600 BRAF-Mutant Metastatic Melanoma: Experience of the SU2C/MRA Melanoma Dream Team
LoRusso, Patricia , Boerner, Scott A. , Forman, Karen, Zuccaro, Clarice Y., Kiefer, Jeffrey , Liang, Winnie S. , Hunsberger, Sally , Redman, Bruce G., Sekulić, Aleksandar , Bryce, Alan H. , Joseph, Richard W. , Cowey, C. Lance , Fecher, Leslie A. , Sosman, Jeffrey A. , Chapman, Paul B. , Craig, David W. , Carpten, John D. , Trent, Jeffrey M. , Pilat, Mary Jo , Markovic, Svetomir N. , Schwartz, Gary K. , Bryce, Alan H

Molecular Cancer Therapeutics | June 11, 2015 | Volume: 14 | Issue: 8 | Pages: 1962-1971

10.1158/1535-7163.mct-15-0153 | PMID 26063764 Get It

Abstract Targeted therapies and immunotherapies have led to significant improvements in the treatment of advanced cancers, including metastatic melanoma. However, new strategies are desperately needed to overcome therapeutic resistance to these agents, as well as to identify effective treatment approaches for cancer patients that fall outside major targetable mutational subtypes (e.g., non–V600 BRAF melanoma). One such strategy is to extend the paradigm of individually tailored, molecularly targeted therapy into a broader spectrum of melanoma patients, particularly those bearing tumors without commonly recognized therapeutic targets, as well as having failed or were ineligible for immunotherapy. In this nontreatment pilot study, next-generation sequencing (NGS) technologies were utilized, including whole genome and whole transcriptome sequencing, to identify molecular aberrations in patients with non–V600 BRAF metastatic melanoma. This information was then rationally matched to an appropriate clinical treatment from a defined pharmacopeia. Five patients with advanced non–V600 BRAF metastatic melanoma were enrolled. We demonstrated successful performance of the following during a clinically relevant time period: patient tumor biopsy, quality DNA/RNA extraction, DNA/RNA-based sequencing for gene expression analysis, analysis utilizing a series of data integration methodologies, report generation, and tumor board review with formulated treatment plan. Streamlining measures were conducted based on the experiences of enrolling, collecting specimens, and analyzing the molecular signatures of patients. We demonstrated the feasibility of using NGS to identify molecular aberrations and generate an individualized treatment plan in this patient population. A randomized treatment study utilizing lessons learned from the conduct of this pilot study is currently underway. Mol Cancer Ther; 14(8); 1962–71. ©2015 AACR.
Autoimmune Epilepsy
Toledano, Michel , Pittock, Sean J. , Pittock, S J

Seminars in Neurology | June 11, 2015 | Volume: 35 | Issue: 03 | Pages: 245-258

10.1055/s-0035-1552625 | PMID 26060904 Get It

Mineral Oil Aspiration Related Juvenile Idiopathic Arthritis
Nelson, Andrew D. , Reed, Ann M. , Wylam, Mark E. , Fischer, Philip R.

Case Reports in Pulmonology | June 11, 2015 | Volume: 2015 | Issue: No issue available | Pages: 1-3

10.1155/2015/403109 | PMID 26171269 Get It

We describe the development of rheumatoid factor-positive migratory polyarthritis in a 5-year-old male who had been administered bidaily oral mineral oil as a laxative since birth. Minor respiratory symptoms, radiographic and bronchoscopic findings were consistent with chronic lipoid pneumonia. We speculate that immune sensitization to mineral oil promoted the clinical syndrome of juvenile idiopathic arthritis.
An anatomic‐based approach to the iatrogenic spinal accessory nerve injury in the posterior cervical triangle: How to avoid and treat it
Cesmebasi, Alper , Spinner, Robert J.

Clinical Anatomy | June 11, 2015 | Volume: 28 | Issue: 6 | Pages: 761-766

10.1002/ca.22555 | PMID 26060941 Get It

Iatrogenic injury of the spinal accessory nerve (SAN) is a significant reducible risk with any invasive procedure involving the posterior cervical triangle. Most commonly associated with cervical lymph node biopsy, it affects 3–6% of patients and serves as a major cause of avoidable medical malpractice litigation. Medical malpractice cases not only affect the primary surgeon but also may include the repairing surgeon through a shift of blame. For this reason, we discuss the strategies all clinicians may utilize in approaching iatrogenic SAN injuries. By taking basic precautionary measures based on simple application of anatomy in the management of these patients, clinicians may protect themselves from needless malpractice litigation. A thorough knowledge of the anatomy and application in preventative strategies may provide guidance for clinicians in reducing the incidence of iatrogenic injuries, providing effective postinjury management, and ensuring the salvaging surgeon is not at fault if litigation is pursued. Clin. Anat. 28:761–766, 2015. © 2015 Wiley Periodicals, Inc.
Genotype-phenotype Correlations of Hypertrophic Cardiomyopathy When Diagnosed in Children, Adolescents, and Young Adults
Loar, Robert W. , Bos, J. Martijn , Will, Melissa L., Ommen, Steve R. , Ackerman, Michael J. , Bos, Johan M

Congenital Heart Disease | June 11, 2015 | Volume: 10 | Issue: 6 | Pages: 529-536

10.1111/chd.12280 | PMID 26061417 Get It

Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease
Goetzl, Edward J. , Boxer, Adam L. , Petersen, Ronald C. , Kapogiannis, Dimitrios , Schwartz, Janice B, Abner, Erin L., Schwartz, Janice B. , Abner, Erin L. , Miller, Bruce L.

Neurology | June 11, 2015 | Volume: 85 | Issue: 1 | Pages: 40-47

10.1212/wnl.0000000000001702 | PMID 26062630 Get It

Automating Quality Metrics in the Era of Electronic Medical Records: Digital Signatures for Ventilator Bundle Compliance
Lan, Haitao , Ahmed, Adil , Herasevich, Vitaly , Sampathkumar, Priya , O’Horo, John C. , O'Horo, John C, Thongprayoon, Charat , Gajic, Ognjen , O'Horo, John C , Herasevich, Vitaly

BioMed Research International | June 11, 2015 | Volume: 2015 | Issue: No issue available | Pages: 1-6

10.1155/2015/396508 | PMID 26167484 Get It

Ventilator-associated events (VAEs) are associated with increased risk of poor outcomes, including death. Bundle practices including thromboembolism prophylaxis, stress ulcer prophylaxis, oral care, and daily sedation breaks and spontaneous breathing trials aim to reduce rates of VAEs and are endorsed as quality metrics in the intensive care units. We sought to create electronic search algorithms (digital signatures) to evaluate compliance with ventilator bundle components as the first step in a larger project evaluating the ventilator bundle effect on VAE. We developed digital signatures of bundle compliance using a retrospective cohort of 542 ICU patients from 2010 for derivation and validation and testing of signature accuracy from a cohort of random 100 patients from 2012. Accuracy was evaluated against manual chart review. Overall, digital signatures performed well, with median sensitivity of 100% (range, 94.4%–100%) and median specificity of 100% (range, 100%–99.8%). Automated ascertainment from electronic medical records accurately assesses ventilator bundle compliance and can be used for quality reporting and research in VAE.
Clinical Diagnosis and Management of Hypertension Compared With the Joint National Committee 8 Panelists' Recommendations
Snipelisky, David , Waldo, Oral, Burton, M. Caroline

Clinical Cardiology | June 11, 2015 | Volume: 38 | Issue: 6 | Pages: 333-343

10.1002/clc.22393 | PMID 26059787 Get It

ABSTRACTBackgroundThe panelists of the Joint National Committee recently published new recommendations for the management of hypertension. Our study aims to evaluate how current practice compares.HypothesisCurrent practice likely deviates from the recent JNC 8 panelists' recommendations.MethodsA survey was sent to cardiology providers at 3 academic medical centers: Mayo Clinic, Jacksonville, Florida; Mayo Clinic, Scottsdale, Arizona; and Mayo Clinic, Rochester, Minnesota. Providers were asked to select which blood‐pressure goal would be deemed appropriate in various cases based on individual practice in both the maintenance of patients already on therapy as well as threshold of when to initiate therapy. Comparisons with current recommendations were made, as well as geographic location and level of experience.ResultsA total of 251 survey requests were sent (May 2014), and 77 responses (30.7%) were received. Cardiologists tended not to practice according to the new guidelines, with most variation seen in patients age >60 years without comorbidities on active treatment. Providers' selection of initial pharmacologic agents in non–African American patients, African American patients, and patients with diabetes mellitus reflected congruency with guidelines.ConclusionsOur study found that clinical practice does not correlate well with the new blood‐pressure goal recommendations published by the Joint National Committee 8 panelists, particularly in patients age >60 years. Practitioners are likely to follow the recommendations in regard to pharmacologic management.